Decode Health collaborates with Quest Diagnostics to speed biomarker discovery for drug and diagnostics development
Features nationally scaled RNA sequencing and specimen collection for multiple sclerosis and non-alcoholic fatty liver…
Browsing: Industry News
Ascidian Therapeutics launches with $50M to rewrite RNA
From Labiotech.eu by Jim Cornall Ascidian Therapeutics, a biotechnology company focused on treating human diseases…
Study reveals spatial heterogeneity in the tumor microenvironment of multiregional clear cell renal cell carcinoma biopsies
BostonGene Corporation announced the publication of a study, conducted in collaboration with researchers at Washington…
Cellarity closes $121M financing, uses single-cell technologies to identify cellular drivers during the transition from health to disease
Cellarity, a life sciences company founded by Flagship Pioneering to transform the way medicines are…
Illumina unveils revolutionary NovaSeq X Series to rapidly accelerate genomic discoveries and improve human health
New technology enables highest levels of accuracy at immense scale, with the power to sequence…
Element Biosciences delivers 1 billion reads and provides industry’s lowest cost for single-cell sequencing
Element Biosciences, developer of an innovative DNA sequencing platform set to disrupt the genomics industry…
Novel RNA sequencing-based liquid biopsy platform demonstrates potential for early detection and monitoring of colorectal cancer
Exai Bio, a next-generation liquid biopsy company, and researchers at UCSF are presenting data from…
CD Genomics RNA-solutions platform announces the launch of Nanopore direct RNA sequencing
CD Genomics has recently launched the Nanopore direct RNA sequencing service for identifying new genes,…
Novogene America Launches a New Single-Cell RNA-Seq Lab Powered by 10x Genomics®
High-throughput sequencing methods mainly based on Illumina platforms have benefited the entire field of biology…
RNA-Seq identifies treatment impact of neurodegenerative drug ANAVEX®2-73
Expression levels of pathological dysregulated neurodegenerative genes of both Alzheimer’s and Parkinson’s disease were significantly…